Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vaccine elicitation and structural basis for antibody protection against alphaviruses.
Sutton MS, Pletnev S, Callahan V, Ko S, Tsybovsky Y, Bylund T, Casner RG, Cerutti G, Gardner CL, Guirguis V, Verardi R, Zhang B, Ambrozak D, Beddall M, Lei H, Yang ES, Liu T, Henry AR, Rawi R, Schön A, Schramm CA, Shen CH, Shi W, Stephens T, Yang Y, Florez MB, Ledgerwood JE, Burke CW, Shapiro L, Fox JM, Kwong PD, Roederer M. Sutton MS, et al. Among authors: callahan v. Cell. 2023 Jun 8;186(12):2672-2689.e25. doi: 10.1016/j.cell.2023.05.019. Epub 2023 Jun 8. Cell. 2023. PMID: 37295404 Free PMC article.
Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays.
Hu Z, López-Muñoz AD, Kosik I, Li T, Callahan V, Brooks K, Yee DS, Holly J, Santos JJS, Castro Brant A, Johnson RF, Takeda K, Zheng ZM, Brenchley JM, Yewdell JW, Fox JM. Hu Z, et al. Among authors: callahan v. Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2310421121. doi: 10.1073/pnas.2310421121. Epub 2024 Jul 8. Proc Natl Acad Sci U S A. 2024. PMID: 38976733 Free PMC article.
Implementation of SARS-CoV-2 Monoclonal Antibody Infusion Sites at Three Medical Centers in the United States: Strengths and Challenges Assessment to Inform COVID-19 Pandemic and Future Public Health Emergency Use.
Lambrou AS, Redd JT, Stewart MA, Rainwater-Lovett K, Thornhill JK, Hayes L, Smith G, Thorp GM, Tomaszewski C, Edward A, Elías Calles N, Amox M, Merta S, Pfundt T, Callahan V, Tewell A, Scharf-Bell H, Imbriale S, Freeman JD, Anderson M, Kadlec RP. Lambrou AS, et al. Among authors: callahan v. Disaster Med Public Health Prep. 2022 Jan 14;17:e112. doi: 10.1017/dmp.2022.15. Disaster Med Public Health Prep. 2022. PMID: 35027098 Free PMC article.
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2.
Azouz NP, Klingler AM, Callahan V, Akhrymuk IV, Elez K, Raich L, Henry BM, Benoit JL, Benoit SW, Noé F, Kehn-Hall K, Rothenberg ME. Azouz NP, et al. Among authors: callahan v. Pathog Immun. 2021 Apr 26;6(1):55-74. doi: 10.20411/pai.v6i1.408. eCollection 2021. Pathog Immun. 2021. PMID: 33969249 Free PMC article.
Hydrogel particles improve detection of SARS-CoV-2 RNA from multiple sample types.
Barclay RA, Akhrymuk I, Patnaik A, Callahan V, Lehman C, Andersen P, Barbero R, Barksdale S, Dunlap R, Goldfarb D, Jones-Roe T, Kelly R, Kim B, Miao S, Munns A, Munns D, Patel S, Porter E, Ramsey R, Sahoo S, Swahn O, Warsh J, Kehn-Hall K, Lepene B. Barclay RA, et al. Among authors: callahan v. Sci Rep. 2020 Dec 30;10(1):22425. doi: 10.1038/s41598-020-78771-8. Sci Rep. 2020. PMID: 33380736 Free PMC article.
Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2.
Azouz NP, Klingler AM, Callahan V, Akhrymuk IV, Elez K, Raich L, Henry BM, Benoit JL, Benoit SW, Noé F, Kehn-Hall K, Rothenberg ME. Azouz NP, et al. Among authors: callahan v. bioRxiv [Preprint]. 2020 Oct 7:2020.05.04.077826. doi: 10.1101/2020.05.04.077826. bioRxiv. 2020. Update in: Pathog Immun. 2021 Apr 26;6(1):55-74. doi: 10.20411/pai.v6i1.408 PMID: 33052338 Free PMC article. Updated. Preprint.
17 results